Retirement + A.I. = Your New Edge While you analyze one ticker, A.I. is already three days ahead.
VantagePoint's patented A.I. processes thousands of intermarket correlations in milliseconds, forecasting price direction before it shows on any chart. That's up to 87.4% proven accuracy, backed by 35+ years of research.
In today's markets, manual analysis isn't just slower. It's losing.
The only question: are you using A.I., or competing against it?
Download your free guide and find out how to put it to work for your retirement portfolio.
DOWNLOAD FREE NOW |
|
|
Top Earnings NewsRezolve Ai Missed Expectations Rezolve Ai (RZLV) reported a loss of $0.38 per share on for the fourth quarter ended December 2025. The consensus estimate was a loss of $0.04 per share on revenue of $20.00 million. The Earnings Whisper number was a loss of $0.04 per share. The company missed expectations by 850.00%.
The company said it expects 2026 revenue of approximately $360.0 million. The company's previous guidance was 2026 revenue of approximately $350.0 million, and the current consensus revenue estimate is $324.25 million for the year ending December 31, 2026.
Rezolve Ai is an industry leader in AI-powered solutions, specializing in enhancing customer engagement, operational efficiency, and revenue growth.
|
Positive GuidanceProgress Software Raises Earnings Guidance Progress Software Corp. (PRGS) said in its earnings presentation it expects second-quarter non-GAAP earnings of $1.47 to $1.53 per share on revenue of $240.0 million to $246.0 million. The current consensus earnings estimate is $1.40 per share on revenue of $240.85 million for the quarter ending May 31, 2026. The company also said it now expects fiscal 2026 non-GAAP earnings of $5.91 to $6.03 per share on revenue of $988.0 million to $1.0 billion. The company's previous guidance was earnings of $5.82 to $5.96 per share on revenue of $986.0 million to $1.0 billion, and the current consensus earnings estimate is $5.88 per share on revenue of $989.52 million for the year ending November 30, 2026.
Progress provides software that enables organizations to develop and deploy their mission-critical applications and experiences, as well as effectively manage their data platforms, cloud and IT infrastructure.
View All Guidance
Negative GuidancePhreesia Lowers Guidance Phreesia, Inc. (PHR) said it expects fiscal 2027 revenue of $510.0 million to $520.0 million. The company's previous guidance was revenue of $545.0 million to $559.0 million, and the current consensus revenue estimate is $550.23 million for the year ending January 31, 2027.
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, consistent experience, while enabling healthcare organizations to enhance clinical care and drive efficiency.
Other Top Guidance Announcements |
|
Beyond Meat is Expected to Miss Estimates Beyond Meat (BYND) is confirmed to report earnings on Tuesday, March 31, 2026 at approximately 5:40 PM ET. The consensus estimate is a loss of $0.12 per share on revenue of $67.85 million, a decline of 11.5% year-over-year, and the Earnings Whisper ® number is a loss of $0.15 per share. Investors are 5.5% bullish going into the company's earnings release. Option traders are pricing in a 70.6% move on earnings and the stock has averaged a 8.6% move in recent quarters.
View Full Calendar
|
|
PAVmed (PAVM) reported a loss of $1.31 per share on revenue of $0.05 million for the fourth quarter ended December 2025. The consensus estimate was a loss of $4.80 per share on revenue of $0.10 million. The company beat consensus estimates by 72.71% while revenue grew 420.00% on a year-over-year basis.
Sangamo Therapeutics (SGMO) reported a loss of $0.07 per share on revenue of $14.23 million for the fourth quarter ended December 2025. The consensus earnings estimate was $0.01 per share on revenue of $35.00 million. The company missed consensus estimates by 800.00% while revenue grew 88.43% on a year-over-year basis.